We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6669:TWSEWiwynn Corporation Analysis

Data as of 2026-03-14 - not real-time

NT$4,070.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Wiwynn Corp. is trading at a 20‑day SMA of 3,929 and a 50‑day SMA of 4,002, with the current price of 4,070 comfortably above both, indicating short‑term price strength. The RSI sits around 53, suggesting neutral momentum, while the MACD shows a bullish histogram of roughly 24 points, reinforcing a modest upside bias. Valuation metrics are attractive: a trailing P/E of 15.3 versus an industry average of 33.7 and a forward P/E near 10 point to a significant discount. The dividend yield of 1.8% is supported by a modest payout ratio of 28%, but negative operating and free cash flow raise questions about long‑term sustainability. Leverage is notable, with a debt‑to‑equity ratio near 83% and total debt exceeding cash reserves, which could pressure balance‑sheet flexibility. Nonetheless, the stock enjoys a low‑to‑moderate beta (~0.96) and a volatility of 53% over the past 30 days, implying market‑aligned risk while still offering a 47% upside‑downside potential according to analyst models.
Analyst consensus is strongly positive, with 16 analysts rating the stock as a “strong buy” and a median price target near 5,950 TWD, implying upside of over 40%. The company’s revenue growth of 152% and ROE of 48% highlight a high‑growth profile, yet thin margins (gross 8.3%, operating 5.6%) and cash‑flow deficits suggest the growth is capital‑intensive. Geopolitical exposure in Taiwan and reliance on USD‑denominated sales introduce medium‑level geographic and currency risks. Overall, the blend of undervalued pricing, robust earnings momentum, and strong analyst support makes Wiwynn an attractive candidate for investors willing to tolerate moderate volatility and balance‑sheet leverage.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram
  • Price above short‑term SMAs
  • Upside potential of ~47%

Medium Term

1–3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong analyst consensus (strong buy)
  • Significant revenue growth and high ROE
  • Attractive valuation relative to industry

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Negative operating and free cash flow
  • High debt‑to‑equity ratio
  • Sustained dividend yield but cash‑flow concerns

Key Metrics & Analysis

Financial Health

Revenue Growth152.90%
Profit Margin5.38%
P/E Ratio15.3
ROE48.03%
ROA15.11%
Debt/Equity83.49
P/B Ratio6.1
Op. Cash FlowNT$-624481024
Free Cash FlowNT$-27850977280
Industry P/E33.7

Technical Analysis

TrendNeutral
RSI53.4
SupportNT$3,520.00
ResistanceNT$4,320.00
MA 20NT$3,929.00
MA 50NT$4,002.00
MA 200NT$3,448.75
MACDBullish
VolumeStable
Fear & Greed Index72.88

Valuation

Target PriceNT$5,996.56
Upside/Downside47.34%
GradeUndervalued
TypeBlend
Dividend Yield1.82%

Risk Assessment

Beta0.96
Volatility52.90%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.